Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma

Oncology

Volumn 55, Issue 4, 1998, Pages 276-283

  Okusaka, Takuji ^a   Okada, Shuichi ^a   Ishii, Hiroshi ^a   Ikeda, Masafumi ^a   Nakasuka, Hidekazu ^a   Nagahama, Hiroyasu ^a   Iwata, Ryoko ^a   Furukawa, Hiroyoshi ^a   Takayasu, Kenichi ^a   Nakanishi, Yukihiro ^b   Sakamoto, Michiie ^b   Hirohashi, Setsuo ^b   Yoshimori, Masayoshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Hepatocellular carcinoma; Transarterial chemotherapy; Zinostatin stimalamer

Indexed keywords

ALPHA FETOPROTEIN; IODINATED POPPYSEED OIL; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG ACCUMULATION; DRUG TOLERABILITY; DRUG TOXICITY; EMULSION; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; MALE; NAUSEA; PRIORITY JOURNAL; SHIVERING; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MALEIC ANHYDRIDES; MIDDLE AGED; POLYSTYRENES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ZINOSTATIN;

EID: 0031840933     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011863     Document Type: Article

References (48)

1. Charnsangavej S, Chuang VP, Wallace S, Soo CS, Bowers T: Transcatheter management of primary carcinoma of the liver. Radiology 1983;147:51-55.
2. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401.
3. Maeda H, Takeshita J, Kanamaru R: A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic. Int J Pept Protein Res 1979;14:81-87.
4. Maeda H, Ueda M, MorinagaT, Matsumoto T: Conjugation of poly (styrene-co-maleic-acid) derivatives to the antitumor protein neocarzinostatin: Pronounced improvements in pharmacological properties. J Med Chem 1985;28: 455-461.
5. Iwai K, Maeda H, Konno T: Use of oil contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and x-ray image. Cancer Res 1984;44:2115-2121.
6. 2 liver tumor in vivo. Jpn J Cancer Chemother 1994;21:219-226.
7. Yamada T, Makita F, Takahara K, Saitou S, Satou K, Endou K, Shimoda R, Matsuzaki Y, Matsumoto T, Yuasa K, Takagi H, Yamada S, Mori M: Evaluation of the therapeutic effect of TAE on primary liver cancer. Cancer Chemother Pharmacol 1994;33(suppl):S55-S59.
8. Takayasu K, Moriyama N, Muramatsu Y, Suzuki M, Yamada T, Kishi K, Hasegawa H, Okazaki N: Hepatic arterial embolization for hepatocellular carcinoma: Comparison of CT scans and resected specimens. Radiology 1984; 150:661-665.
9. Shimamura Y, Ishii M, Ono M, Makita F, Sekiguchi R, Yoshino M, Gunven P, Abe K: Arterial infusion therapy: Lipiodol-cytostatics with and without embolization; in Tobe T (ed): Primary Liver Cancer in Japan. Tokyo, Springer, 1992, p 273.
10. Imaeda T, Yamawaki Y, Seki M, Goto H, Iinuma G, Kanematsu M, Mochizuki R, Doi H, Saji S, Shimokawa K: Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: Correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol 1993; 16:209-213.
11. Jinno K, Moriwaki S, Tanaka M, Wada T, Mandai K, Okada Y: Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31(suppl I):S7-S12.
12. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5: 649-655.
13. Liver Cancer Study Group of Japan: The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, ed 3 (in Japanese). Tokyo, Kanehara-Shuppan, 1992.
14. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. Genova, World Health Organization, 1979, vol 48.
15. Kraybill WG, Harrison M, Sasaki T, Fletcher WS: Regional intra-arterial infusion of adriamycin in the treatment of cancer. Surg Gynecol Obstet 1977;144:335-338.
16. Lee YTN, Irwin L: Hepatic artery ligation and adriamycin infusion chemotherapy for hepatoma. Cancer 1978;41:1249-1255.
17. Sundqvist K, Hafstrom LO, Jonsson PE, Ryden S, Forsberg L, Lunderquist A: Treatment of liver cancer with regional intraarterial 5-FU infusion. Am J Surg 1978;136:328-331.
18. Ansfield FJ, Ramirez G, Davis HL Jr, Wirtanen GW, Johnson RO, Bryan GT, Manalo FB, Borden EC, Davis TE, Esmili M: Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil. Cancer 1975;36:2413-2417.
19. Ramming KP, Sparks FC, Eilber FR, Holmes EC, Morton DL: Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. Am J Surg 1976; 132:236-242.
20. Al-Sarraf M, Go Ts, Kithier K, Vaitkevicius ZK: Primary liver cancer: A review of the clinical features, blood groups, serum enzymes, therapy and survival of 65 cases. Cancer 1974; 33:574-584.
21. Reed ML, Vaitkevicius VK, Al-Sarraf M, Vaughn CB, Singhakowinta A, Sexon-Porte M, Izbicki R, Baker L, Straatsma GW: The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results of 124 patients in a prospective protocol. Cancer 1981;47:402-409.
22. Cady B, Oberfield RA: Arterial infusion chemotherapy of hepatoma. Surg Gynecol Obstet 1974;138:381-384.
23. Sullivan RD: Systemic and arterial infusion chemotherapy for metastatic liver cancer. Int J Rad Oncol Biol Phys 1976;1:973-976.
24. Buchwald H, Grage TB, Vassilopoulos PP, Rohde TD, Varco RL, Blackshear PJ: Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 1980;45:866-869.
25. Kinami Y, Miyazaki I: The superselective and the selective one shot methods for treating inoperable cancer of the liver. Cancer 1978;41: 1720-1727.
26. Misra NC, Jaiswal MS, Singh RV, Das B: Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma. Cancer 1977;39:1425-1429.
27. Lise M, Cagol PP, Nitti D, Feltrin G, Fosser V, Cecchetto A, Rubaltelli L, Pucciarelli S: Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver. Int Surg 1980;65:315-323.
28. Patt YZ, Charnsangavej C, Yoffe B, Smith R, Lawrence D, Chuang V, Carrasco H, Roh M, Chase J, Fischer H, Jones D, Levin B: Hepatic arterial infusion of fluoxuridine, leucovolin, doxorubicin, and cisplatin for hepatocellular carcinoma: Effects of hepatitis B and C viral injection on drug toxicity and patient survival. J Clin Oncol 1994;12:1204-1211.
29. Minoyama A, Yoshikawa M, Ebara M, Saisho H, Sugiura N, Ohio M: Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma. J Gastroenterol 1995; 30:356-366.
30. Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishizaki T, Hasuo K, Sugimachi K: A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989;10:98-102.
31. Shibata J, Fujiyama S, Sato T, Kishimoto S, Fukushima S, Nakano M: Hepatic arterial injection chemotherapy with cisplatin suspended in oily lymphographic agent for hepatocellular carcinoma. Cancer 1989;64:1586-1594.
32. Leung WT, Shiu WCT, Leung N, Chan M, Tao M, Li AKC, Metreweli C: Treatment of inoperable hepatocellular carcinoma by intra-arterial lipiodol and 4′-epidoxorubicin. Cancer Chemother Pharmacol 1992;29:401-404.
33. Ichikawa W, Togo S, Osanai T, Miyanaga T, Sawai S, Yamashita T, Kawachi Y, Nihei Z, Hirayama R, Mishima Y: Clinical study on the effect of the intra-arterial injection of mitoxantrone-lipiodol emulsion for hepatocellular carcinoma. Jpn J Cancer Chemother 1994;21: 2212-2214.
34. Inoue H, Miyazono N, Hori A, Miyake S, Satake M, Kanetsuki I, Nishida H, Ikeda K, Nakajo M: Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/ mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP). Acta Radiol 1993;34:388-391.
35. Ichida T, Kato M, Hayakawa A, Ito S, Mori S, Sato T, Sugitani S, Sato H, Watanabe M, Asakura H: Therapeutic effect of a CDDP-epirubicin-lipiodol emulsion on advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33(suppl):S74-S78.
36. Groupe D'Etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261.
37. Maeda H, Seymour LW, Miyamoto Y: Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconjugate Chem 1992;3:351-362.
38. Maeda H, Matsumura Y: Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989;6: 193-210.
39. Li CJ, Miyamoto Y, Kojima Y, Maeda H: Augmentation of tumor delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure. Br J Cancer 1993; 67:975-980.
40. Maeda H, Matsumoto T, Konno T, Iwai K, Ueda M: Tailor making of protein drugs by polymer conjugation for tumor targeting: A brief review on SMANCS. J Protein Chem 1984;3:181-193.
41. Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, Mochinaga M, Hiraoka T, Yokoyama I: Effect of arterial administration of high-molecular weight anti-cancer agent, SMANCS, with lipid lymphographic agent on hepatoma: A preliminary report. Eur J Cancer Clin Oncol 1983;19:1053.
42. Konno T: Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodol. Eur J Cancer 1992;28: 403-409.
43. Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH: Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. Cancer 1994;74:2449-2453.
44. Takayasu K, Furukawa H, Wako F, Muramatsu Y, Abe H, Terauchi T, Winter TC 3rd, Sakamoto M, Hirohashi S: CT diagnosis of early hepatocellular carcinoma: Sensitivity, findings, and CT-pathologic correlation. AJR Am J Roentgenol 1995;164:885-890.
45. Nakakuma K, Tashiro S, Hiraoka T, Ogata K, Ootsuka K: Hepatocellular carcinoma and metastatic cancer detected by iodized oil. Radiology 1985;154:15-17.
46. Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okuda K: Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154:19-24.
47. Ohishi H, Uchida H, Yoshimura H, Ohue S, Ueda J, Katsuragi M, Matsuo N, Hosogi Y: Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 1985; 154:25-29.
48. Sakurai M, Okamura J, Kuroda C: Transcatheter chemoembolization effective for treating hepatocellular carcinoma: A histopathologic study. Cancer 1984;54:387-392.